SEM
Select Medical Holdings Corporation
SEM
(2.5)35,36 USD
6.11% ROA
17.79% ROE
14.08x PER
3.437.417.340,00 USD
327.7% DER
1.86% Yield
3.65% NPM
Select Medical Holdings Corporation Stock Analysis
Select Medical Holdings Corporation Fundamental Analysis
Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.
| # | Analysis | Rating |
|---|---|---|
| 1 |
ROE
ROE surpassing expectations (17.9%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect. |
|
| 2 |
Revenue Growth
Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity. |
|
| 3 |
ROA
The stock's ROA (6.11%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits. |
|
| 4 |
PBV
The stock's PBV ratio (2.26x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns. |
|
| 5 |
Assets Growth
Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice. |
|
| 6 |
Dividend Growth
The company's dividend growth has shown a positive trajectory over the past three years, consistently increasing year after year, indicating a favorable trend for potential investors. |
|
| 7 |
Dividend
The company's track record of consistently paying dividends in the last three years highlights its dedication to providing investors with regular income. |
|
| 8 |
Buffet Intrinsic Value
Based on Warren Buffett's formula, the company's stock appears undervalued (729), presenting an attractive investment chance with its intrinsic value surpassing the current market price. |
|
| 9 |
DER
The company has a high debt to equity ratio (394%), which means it owes a lot of money compared to what it actually owns, making it financially risky. |
|
| 10 |
Net Profit Growth
Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect. |
|
| 11 |
Graham Number
Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice. |
Select Medical Holdings Corporation Technical Analysis
Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.
| # | Analysis | Recommendation |
|---|---|---|
| 1 | Awesome Oscillator | Hold |
| 2 | MACD | Buy |
| 3 | RSI | Hold |
| 4 | Stoch RSI | Sell |
Select Medical Holdings Corporation Price Chart
Financial Statements
Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.
Income Statements
An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.
Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.
| Year | Revenue | Growth |
|---|---|---|
| 2005 | 1.858.442.000 | |
| 2006 | 1.851.498.000 | -0.38% |
| 2007 | 1.991.666.000 | 7.04% |
| 2008 | 2.153.362.000 | 7.51% |
| 2009 | 2.239.871.000 | 3.86% |
| 2010 | 2.390.290.000 | 6.29% |
| 2011 | 2.804.507.000 | 14.77% |
| 2012 | 2.948.969.000 | 4.9% |
| 2013 | 2.975.648.000 | 0.9% |
| 2014 | 3.065.017.000 | 2.92% |
| 2015 | 3.742.736.000 | 18.11% |
| 2016 | 4.286.021.000 | 12.68% |
| 2017 | 4.443.603.000 | 3.55% |
| 2018 | 5.081.258.000 | 12.55% |
| 2019 | 5.453.922.000 | 6.83% |
| 2020 | 5.531.713.000 | 1.41% |
| 2021 | 6.204.515.000 | 10.84% |
| 2022 | 6.333.538.000 | 2.04% |
| 2023 | 6.662.776.000 | 4.94% |
Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.
| Year | Research and Development Expenses | Growth |
|---|---|---|
| 2005 | 0 | |
| 2006 | 0 | 0% |
| 2007 | 0 | 0% |
| 2008 | 0 | 0% |
| 2009 | 0 | 0% |
| 2010 | 0 | 0% |
| 2011 | 0 | 0% |
| 2012 | 0 | 0% |
| 2013 | 0 | 0% |
| 2014 | 0 | 0% |
| 2015 | 0 | 0% |
| 2016 | 0 | 0% |
| 2017 | 0 | 0% |
| 2018 | 0 | 0% |
| 2019 | 0 | 0% |
| 2020 | 0 | 0% |
| 2021 | 0 | 0% |
| 2022 | 0 | 0% |
| 2023 | 0 | 0% |
General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.
| Year | General and Administrative Expenses | Growth |
|---|---|---|
| 2005 | 0 | |
| 2006 | 182.003.000 | 100% |
| 2007 | 0 | 0% |
| 2008 | 0 | 0% |
| 2009 | 72.409.000 | 100% |
| 2010 | 62.121.000 | -16.56% |
| 2011 | 62.354.000 | 0.37% |
| 2012 | 66.194.000 | 5.8% |
| 2013 | 76.921.000 | 13.95% |
| 2014 | 85.247.000 | 9.77% |
| 2015 | 92.052.000 | 7.39% |
| 2016 | 106.927.000 | 13.91% |
| 2017 | 114.047.000 | 6.24% |
| 2018 | 121.268.000 | 5.95% |
| 2019 | 128.463.000 | 5.6% |
| 2020 | 138.037.000 | 6.94% |
| 2021 | 146.975.000 | 6.08% |
| 2022 | 153.035.000 | 3.96% |
| 2023 | 165.264.000 | 7.4% |
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.
| Year | EBITDA | Growth |
|---|---|---|
| 2005 | 164.403.000 | |
| 2006 | 305.773.000 | 46.23% |
| 2007 | 253.073.000 | -20.82% |
| 2008 | 268.665.000 | 5.8% |
| 2009 | 307.960.000 | 12.76% |
| 2010 | 305.035.000 | -0.96% |
| 2011 | 385.481.000 | 20.87% |
| 2012 | 446.930.000 | 13.75% |
| 2013 | 405.727.000 | -10.16% |
| 2014 | 404.474.000 | -0.31% |
| 2015 | 485.601.000 | 16.71% |
| 2016 | 576.845.000 | 15.82% |
| 2017 | 616.385.000 | 6.41% |
| 2018 | 649.855.000 | 5.15% |
| 2019 | 709.446.000 | 8.4% |
| 2020 | 802.756.000 | 11.62% |
| 2021 | 966.197.000 | 16.92% |
| 2022 | 635.515.000 | -52.03% |
| 2023 | 5.824.640.000 | 89.09% |
Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.
| Year | Gross Profit | Growth |
|---|---|---|
| 2005 | 369.760.000 | |
| 2006 | 366.866.000 | -0.79% |
| 2007 | 331.617.000 | -10.63% |
| 2008 | 361.521.000 | 8.27% |
| 2009 | 420.100.000 | 13.94% |
| 2010 | 408.111.000 | -2.94% |
| 2011 | 495.937.000 | 17.71% |
| 2012 | 505.419.000 | 1.88% |
| 2013 | 480.172.000 | -5.26% |
| 2014 | 482.677.000 | 0.52% |
| 2015 | 531.195.000 | 9.13% |
| 2016 | 621.178.000 | 14.49% |
| 2017 | 709.427.000 | 12.44% |
| 2018 | 740.202.000 | 4.16% |
| 2019 | 812.920.000 | 8.95% |
| 2020 | 821.341.000 | 1.03% |
| 2021 | 919.366.000 | 10.66% |
| 2022 | 733.377.000 | -25.36% |
| 2023 | 892.740.000 | 17.85% |
Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.
| Year | Net Profit | Growth |
|---|---|---|
| 2005 | -27.924.000 | |
| 2006 | 94.879.000 | 129.43% |
| 2007 | 35.430.000 | -167.79% |
| 2008 | 22.441.000 | -57.88% |
| 2009 | 75.282.000 | 70.19% |
| 2010 | 77.644.000 | 3.04% |
| 2011 | 107.846.000 | 28% |
| 2012 | 148.230.000 | 27.24% |
| 2013 | 114.390.000 | -29.58% |
| 2014 | 120.627.000 | 5.17% |
| 2015 | 130.736.000 | 7.73% |
| 2016 | 115.411.000 | -13.28% |
| 2017 | 177.184.000 | 34.86% |
| 2018 | 137.840.000 | -28.54% |
| 2019 | 201.031.000 | 31.43% |
| 2020 | 258.995.000 | 22.38% |
| 2021 | 402.225.000 | 35.61% |
| 2022 | 158.994.000 | -152.98% |
| 2023 | 192.720.000 | 17.5% |
EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.
| Year | Earning per Share (EPS) | Growth |
|---|---|---|
| 2005 | 0 | |
| 2006 | 1 | 100% |
| 2007 | 0 | 0% |
| 2008 | 0 | 0% |
| 2009 | 1 | 0% |
| 2010 | 0 | 0% |
| 2011 | 1 | 0% |
| 2012 | 1 | 100% |
| 2013 | 1 | 0% |
| 2014 | 1 | 0% |
| 2015 | 1 | 100% |
| 2016 | 1 | 0% |
| 2017 | 1 | 100% |
| 2018 | 1 | 0% |
| 2019 | 2 | 0% |
| 2020 | 2 | 0% |
| 2021 | 3 | 50% |
| 2022 | 1 | -100% |
| 2023 | 2 | 0% |
Cashflow Statements
Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.
Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.
| Year | Free Cashflow | Growth |
|---|---|---|
| 2005 | -52.735.000 | |
| 2006 | 72.555.000 | 172.68% |
| 2007 | -80.061.000 | 190.62% |
| 2008 | 50.934.000 | 257.19% |
| 2009 | 107.762.000 | 52.73% |
| 2010 | 92.776.000 | -16.15% |
| 2011 | 171.112.000 | 45.78% |
| 2012 | 230.497.000 | 25.76% |
| 2013 | 118.863.000 | -93.92% |
| 2014 | 75.396.000 | -57.65% |
| 2015 | 25.773.000 | -192.54% |
| 2016 | 184.970.000 | 86.07% |
| 2017 | 4.888.000 | -3684.17% |
| 2018 | 326.913.000 | 98.5% |
| 2019 | 288.056.000 | -13.49% |
| 2020 | 881.633.000 | 67.33% |
| 2021 | 220.691.000 | -299.49% |
| 2022 | 94.453.000 | -133.65% |
| 2023 | 66.140.000 | -42.81% |
Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.
| Year | Operating Cashflow | Growth |
|---|---|---|
| 2005 | 57.211.000 | |
| 2006 | 227.651.000 | 74.87% |
| 2007 | 86.013.000 | -164.67% |
| 2008 | 107.438.000 | 19.94% |
| 2009 | 165.639.000 | 35.14% |
| 2010 | 144.537.000 | -14.6% |
| 2011 | 217.128.000 | 33.43% |
| 2012 | 298.682.000 | 27.3% |
| 2013 | 192.523.000 | -55.14% |
| 2014 | 170.642.000 | -12.82% |
| 2015 | 208.415.000 | 18.12% |
| 2016 | 346.603.000 | 39.87% |
| 2017 | 238.131.000 | -45.55% |
| 2018 | 494.194.000 | 51.81% |
| 2019 | 445.182.000 | -11.01% |
| 2020 | 1.028.073.000 | 56.7% |
| 2021 | 401.228.000 | -156.23% |
| 2022 | 284.825.000 | -40.87% |
| 2023 | 116.338.000 | -144.83% |
Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.
| Year | Capital Expenditure | Growth |
|---|---|---|
| 2005 | 109.946.000 | |
| 2006 | 155.096.000 | 29.11% |
| 2007 | 166.074.000 | 6.61% |
| 2008 | 56.504.000 | -193.92% |
| 2009 | 57.877.000 | 2.37% |
| 2010 | 51.761.000 | -11.82% |
| 2011 | 46.016.000 | -12.48% |
| 2012 | 68.185.000 | 32.51% |
| 2013 | 73.660.000 | 7.43% |
| 2014 | 95.246.000 | 22.66% |
| 2015 | 182.642.000 | 47.85% |
| 2016 | 161.633.000 | -13% |
| 2017 | 233.243.000 | 30.7% |
| 2018 | 167.281.000 | -39.43% |
| 2019 | 157.126.000 | -6.46% |
| 2020 | 146.440.000 | -7.3% |
| 2021 | 180.537.000 | 18.89% |
| 2022 | 190.372.000 | 5.17% |
| 2023 | 50.198.000 | -279.24% |
Balance Sheet
Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.
Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.
| Year | Equity | Growth |
|---|---|---|
| 2005 | -244.658.000 | |
| 2006 | -169.139.000 | -44.65% |
| 2007 | -165.889.000 | -1.96% |
| 2008 | -174.204.000 | 4.77% |
| 2009 | 769.555.000 | 122.64% |
| 2010 | 815.414.000 | 5.62% |
| 2011 | 855.326.000 | 4.67% |
| 2012 | 745.478.000 | -14.74% |
| 2013 | 818.642.000 | 8.94% |
| 2014 | 775.240.000 | -5.6% |
| 2015 | 908.517.000 | 14.67% |
| 2016 | 905.901.000 | -0.29% |
| 2017 | 932.604.000 | 2.86% |
| 2018 | 1.029.438.000 | 9.41% |
| 2019 | 1.087.098.000 | 5.3% |
| 2020 | 1.252.973.000 | 13.24% |
| 2021 | 1.580.856.000 | 20.74% |
| 2022 | 1.586.216.000 | 0.34% |
| 2023 | 1.550.388.000 | -2.31% |
Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.
| Year | Assets | Growth |
|---|---|---|
| 2005 | 2.168.385.000 | |
| 2006 | 2.182.524.000 | 0.65% |
| 2007 | 2.495.046.000 | 12.53% |
| 2008 | 2.579.469.000 | 3.27% |
| 2009 | 2.602.233.000 | 0.87% |
| 2010 | 2.722.086.000 | 4.4% |
| 2011 | 2.772.147.000 | 1.81% |
| 2012 | 2.761.361.000 | -0.39% |
| 2013 | 2.817.622.000 | 2% |
| 2014 | 2.924.809.000 | 3.66% |
| 2015 | 4.426.666.000 | 33.93% |
| 2016 | 4.944.395.000 | 10.47% |
| 2017 | 5.127.166.000 | 3.56% |
| 2018 | 5.964.265.000 | 14.04% |
| 2019 | 7.340.288.000 | 18.75% |
| 2020 | 7.655.399.000 | 4.12% |
| 2021 | 7.360.171.000 | -4.01% |
| 2022 | 7.665.293.000 | 3.98% |
| 2023 | 7.684.008.000 | 0.24% |
Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.
| Year | Liabilities | Growth |
|---|---|---|
| 2005 | 2.408.687.000 | |
| 2006 | 2.349.097.000 | -2.54% |
| 2007 | 2.655.174.000 | 11.53% |
| 2008 | 2.745.870.000 | 3.3% |
| 2009 | 1.832.678.000 | -49.83% |
| 2010 | 1.906.672.000 | 3.88% |
| 2011 | 1.916.821.000 | 0.53% |
| 2012 | 2.015.883.000 | 4.91% |
| 2013 | 1.998.980.000 | -0.85% |
| 2014 | 2.149.569.000 | 7.01% |
| 2015 | 3.518.149.000 | 38.9% |
| 2016 | 4.038.494.000 | 12.88% |
| 2017 | 4.194.562.000 | 3.72% |
| 2018 | 5.048.025.000 | 16.91% |
| 2019 | 6.411.253.000 | 21.26% |
| 2020 | 6.402.426.000 | -0.14% |
| 2021 | 6.034.269.000 | -6.1% |
| 2022 | 6.308.729.000 | 4.35% |
| 2023 | 6.133.620.000 | -2.85% |
Select Medical Holdings Corporation Financial Ratio (TTM)
Valuation Metrics
- Revenue per Share
- 53.38
- Net Income per Share
- 1.9
- Price to Earning Ratio
- 14.08x
- Price To Sales Ratio
- 0.52x
- POCF Ratio
- 7.97
- PFCF Ratio
- 17.97
- Price to Book Ratio
- 2.17
- EV to Sales
- 1.27
- EV Over EBITDA
- 4.11
- EV to Operating CashFlow
- 20.12
- EV to FreeCashFlow
- 43.66
- Earnings Yield
- 0.07
- FreeCashFlow Yield
- 0.06
- Market Cap
- 3,44 Bil.
- Enterprise Value
- 8,35 Bil.
- Graham Number
- 23
- Graham NetNet
- -43.34
Income Statement Metrics
- Net Income per Share
- 1.9
- Income Quality
- 1.51
- ROE
- 0.17
- Return On Assets
- 0.03
- Return On Capital Employed
- 0.07
- Net Income per EBT
- 0.64
- EBT Per Ebit
- 0.9
- Ebit per Revenue
- 0.06
- Effective Tax Rate
- 0.22
Margins
- Sales, General, & Administrative to Revenue
- 0.03
- Research & Developement to Revenue
- 0
- Stock Based Compensation to Revenue
- 0.01
- Gross Profit Margin
- 0.14
- Operating Profit Margin
- 0.06
- Pretax Profit Margin
- 0.06
- Net Profit Margin
- 0.04
Dividends
- Dividend Yield
- 0.02
- Dividend Yield %
- 1.86
- Payout Ratio
- 0.27
- Dividend Per Share
- 0.5
Operating Metrics
- Operating Cashflow per Share
- 3.36
- Free CashFlow per Share
- 1.55
- Capex to Operating CashFlow
- -0.54
- Capex to Revenue
- -0.03
- Capex to Depreciation
- -1.08
- Return on Invested Capital
- 0.04
- Return on Tangible Assets
- 0.06
- Days Sales Outstanding
- 52.32
- Days Payables Outstanding
- 11.74
- Days of Inventory on Hand
- 0
- Receivables Turnover
- 6.98
- Payables Turnover
- 31.1
- Inventory Turnover
- 0
- Capex per Share
- -1.81
Balance Sheet
- Cash per Share
- 0,63
- Book Value per Share
- 12,35
- Tangible Book Value per Share
- -18.56
- Shareholders Equity per Share
- 12.35
- Interest Debt per Share
- 41.22
- Debt to Equity
- 3.28
- Debt to Assets
- 0.65
- Net Debt to EBITDA
- 2.42
- Current Ratio
- 1.09
- Tangible Asset Value
- -2,29 Bil.
- Net Current Asset Value
- -4,86 Bil.
- Invested Capital
- 3.28
- Working Capital
- 0,11 Bil.
- Intangibles to Total Assets
- 0.5
- Average Receivables
- 0,95 Bil.
- Average Payables
- 0,18 Bil.
- Average Inventory
- 8256500
- Debt to Market Cap
- 1.45
Dividends
Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.
| Year | Dividends | Growth |
|---|---|---|
| 2012 | 2 | |
| 2013 | 0 | 0% |
| 2014 | 0 | 0% |
| 2015 | 0 | 0% |
| 2021 | 0 | 0% |
| 2022 | 1 | 0% |
| 2023 | 1 | 0% |
Select Medical Holdings Corporation Profile
About Select Medical Holdings Corporation
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. Its Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The company's Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. Its Concentra segment operates and provides occupational health centers and contract services at employer worksites that deliver occupational medicine, consumer health, physical therapy, and wellness services. As of December 31, 2021, the company operated 104 critical illness recovery hospitals in 28 states; 30 rehabilitation hospitals in 12 states; 1,881 outpatient rehabilitation clinics in 38 states and the District of Columbia; and 518 occupational health centers in 41 states, and 134 onsite clinics at employer worksites states. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.
- CEO
- Mr. David S. Chernow
- Employee
- 38.400
- Address
-
4714 Gettysburg Road
Mechanicsburg, 17055
Select Medical Holdings Corporation Executives & BODs
| # | Name | Age |
|---|---|---|
| 1 |
Mary Lacey Senior Vice President & Chief Human Resources Officer |
70 |
| 2 |
Bridget Sherick Senior Vice President of Accounting for Shared Services |
70 |
| 3 |
Mr. Robert G. Breighner Jr. Senior Vice President of Compliance & Audit |
70 |
| 4 |
John Duggan Executive Vice President & Deputy General Counsel |
70 |
| 5 |
Mr. David S. Chernow Chief Executive Officer |
70 |
| 6 |
Shelly Eckenroth Senior Vice President & Chief Communications, Marketing and Branding Officer |
70 |
| 7 |
Mr. Christopher S. Weigl Senior Vice President, Controller & Chief Accounting Officer |
70 |
| 8 |
Mr. Brian R. Rusignuolo Executive Vice President & Chief Information Officer |
70 |
| 9 |
Mr. Robert A. Ortenzio Co-Founder & Executive Chairman |
70 |
| 10 |
Mr. Rocco A. Ortenzio Co-Founder & Vice Chairman |
70 |
Select Medical Holdings Corporation Competitors
